2) fluticasone
氟替卡松
1.
Safety Evaluation of Children with Asthma and Improvement in Inhalation Fluticasone Continued
持续吸入氟替卡松对哮喘儿童肺功能的改善及安全性评价
2.
Objective To observe the effects of asthmatic children treated by inhaled salmeterol xinafoate and fluticasone propi-onate powder.
方法应用沙美特罗替卡松干粉剂吸入治疗4-14岁非急性发作期中、重度哮喘140例,与对照组应用氟替卡松吸入治疗哮喘106例作比较,同时监测肺功能结果治疗组和对照组总有效率分别为99。
3.
AIM:To observe the effects of the inhaled fluticasone in treating pediatrics asthma.
目的 :观察氟替卡松吸入治疗儿童哮喘的效果。
3) Ticabesone
替卡贝松
4) Fluticasone propionate
丙酸氟替卡松
1.
Effect of fluticasone propionate on airway remodeling and TGF-β_1 expression in murine models of asthma;
丙酸氟替卡松对哮喘小鼠气道重塑及TGF-β_1表达的影响
2.
Differential effects of fluticasone propionate(FP) on gene expression in airway epithelial cells;
丙酸氟替卡松对呼吸道上皮细胞基因表达的不同作用
5) Fluticasone propionate
氟替卡松丙酸酯
1.
Fluticasone propionate [(S)-fluoromethyl-6α,9α-difluoro-11β-hydroxy-16α-methyl-3-oxo-17α-(propionyloxy)-androsta-1,4-diene-17β-carbothioate; FP] is a synthetic, trifluorinated glucocorticosteroid.
氟替卡松丙酸酯化学名称S-6α,9α-二氟-11β-羟基-17α-丙酰氧基-16α-甲基-3-氧代雄甾-1,4-二烯-17β-硫代羟酸氟甲基酯,为化学合成的三氟化糖皮质激素类药物,是由德国葛兰素威康(Glaxo Wellcome)有限公司开发,并于1993年首次上市,具有较强的抗炎作用,临床上用于治疗哮喘。
6) Salmeterol/fluticasone propionate
沙美特罗替卡松
1.
Lung function and safety of children with moderate-severe asthma treated by salmeterol/fluticasone propionate;
沙美特罗替卡松治疗儿童中重度哮喘的肺功能及安全性观察
补充资料：氟替卡松
分子式：暂无
分子量：暂无
CAS号：暂无
性质：暂无
制备方法：暂无
用途：暂无
分子量：暂无
CAS号：暂无
性质：暂无
制备方法：暂无
用途：暂无
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条